Correlation between Serological Biomarkers and Disease Activity in Patients with Inflammatory Bowel Disease

Background. Current biomarkers have been routinely used noninvasive methods for assessing disease activity of inflammatory bowel disease (IBD), but none of them are specific. This study was aimed to determine the performance of the serological biomarkers for detecting disease activity in patients wi...

Full description

Bibliographic Details
Main Authors: Mengque Xu, Mengsha Cen, Xiaoli Chen, Haotian Chen, Xing Liu, Qian Cao
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2019/6517549
id doaj-332f46389c6549d0b7c45bcaeeb84ee4
record_format Article
spelling doaj-332f46389c6549d0b7c45bcaeeb84ee42020-11-25T00:12:54ZengHindawi LimitedBioMed Research International2314-61332314-61412019-01-01201910.1155/2019/65175496517549Correlation between Serological Biomarkers and Disease Activity in Patients with Inflammatory Bowel DiseaseMengque Xu0Mengsha Cen1Xiaoli Chen2Haotian Chen3Xing Liu4Qian Cao5Department of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaDepartment of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaDepartment of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaDepartment of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaDepartment of Medical Records and Statistics, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaDepartment of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaBackground. Current biomarkers have been routinely used noninvasive methods for assessing disease activity of inflammatory bowel disease (IBD), but none of them are specific. This study was aimed to determine the performance of the serological biomarkers for detecting disease activity in patients with IBD. Methods. A prospective study that included 73 ulcerative disease (UC) subjects, 141 Crohn’s disease (CD) subjects, and 30 of them complicated with C. difficile infection (CDI) were diagnosed at a single-institution IBD center. Disease activity was assessed using by Truelove and Witts criteria for UC and Harvey Bradshaw Simple Index for CD. Serological inflammatory biomarkers were compared in different severity groups. Receiver operator curve analyses assessed the performance of each biomarker in discriminating disease states. Results. For UC patients, elevated monocyte counts, C-reactive protein (CRP), and decreased lymphocyte counts and lymphocyte/monocyte ratio (LMR) significantly differed between subjects with active and inactive UC. LMR of 3.1 was 76% sensitive and had a specificity of 67% for active UC. For CD patients, higher values of neutrophils, monocytes, neutrophil/lymphocyte ratio, CRP, fibrinogen, and lower values of LMR and hemoglobin were significantly different between subjects with active and inactive CD. None of the biomarkers included had a good correlation with disease activity (area under the ROC Curve < 0.70). Conclusions. A low LMR represents an inexpensive, readily available test with a promising value to identify disease activity in UC patients, whereas none of the inflammatory biomarkers showed a discriminative value in disease activity of CD.http://dx.doi.org/10.1155/2019/6517549
collection DOAJ
language English
format Article
sources DOAJ
author Mengque Xu
Mengsha Cen
Xiaoli Chen
Haotian Chen
Xing Liu
Qian Cao
spellingShingle Mengque Xu
Mengsha Cen
Xiaoli Chen
Haotian Chen
Xing Liu
Qian Cao
Correlation between Serological Biomarkers and Disease Activity in Patients with Inflammatory Bowel Disease
BioMed Research International
author_facet Mengque Xu
Mengsha Cen
Xiaoli Chen
Haotian Chen
Xing Liu
Qian Cao
author_sort Mengque Xu
title Correlation between Serological Biomarkers and Disease Activity in Patients with Inflammatory Bowel Disease
title_short Correlation between Serological Biomarkers and Disease Activity in Patients with Inflammatory Bowel Disease
title_full Correlation between Serological Biomarkers and Disease Activity in Patients with Inflammatory Bowel Disease
title_fullStr Correlation between Serological Biomarkers and Disease Activity in Patients with Inflammatory Bowel Disease
title_full_unstemmed Correlation between Serological Biomarkers and Disease Activity in Patients with Inflammatory Bowel Disease
title_sort correlation between serological biomarkers and disease activity in patients with inflammatory bowel disease
publisher Hindawi Limited
series BioMed Research International
issn 2314-6133
2314-6141
publishDate 2019-01-01
description Background. Current biomarkers have been routinely used noninvasive methods for assessing disease activity of inflammatory bowel disease (IBD), but none of them are specific. This study was aimed to determine the performance of the serological biomarkers for detecting disease activity in patients with IBD. Methods. A prospective study that included 73 ulcerative disease (UC) subjects, 141 Crohn’s disease (CD) subjects, and 30 of them complicated with C. difficile infection (CDI) were diagnosed at a single-institution IBD center. Disease activity was assessed using by Truelove and Witts criteria for UC and Harvey Bradshaw Simple Index for CD. Serological inflammatory biomarkers were compared in different severity groups. Receiver operator curve analyses assessed the performance of each biomarker in discriminating disease states. Results. For UC patients, elevated monocyte counts, C-reactive protein (CRP), and decreased lymphocyte counts and lymphocyte/monocyte ratio (LMR) significantly differed between subjects with active and inactive UC. LMR of 3.1 was 76% sensitive and had a specificity of 67% for active UC. For CD patients, higher values of neutrophils, monocytes, neutrophil/lymphocyte ratio, CRP, fibrinogen, and lower values of LMR and hemoglobin were significantly different between subjects with active and inactive CD. None of the biomarkers included had a good correlation with disease activity (area under the ROC Curve < 0.70). Conclusions. A low LMR represents an inexpensive, readily available test with a promising value to identify disease activity in UC patients, whereas none of the inflammatory biomarkers showed a discriminative value in disease activity of CD.
url http://dx.doi.org/10.1155/2019/6517549
work_keys_str_mv AT mengquexu correlationbetweenserologicalbiomarkersanddiseaseactivityinpatientswithinflammatoryboweldisease
AT mengshacen correlationbetweenserologicalbiomarkersanddiseaseactivityinpatientswithinflammatoryboweldisease
AT xiaolichen correlationbetweenserologicalbiomarkersanddiseaseactivityinpatientswithinflammatoryboweldisease
AT haotianchen correlationbetweenserologicalbiomarkersanddiseaseactivityinpatientswithinflammatoryboweldisease
AT xingliu correlationbetweenserologicalbiomarkersanddiseaseactivityinpatientswithinflammatoryboweldisease
AT qiancao correlationbetweenserologicalbiomarkersanddiseaseactivityinpatientswithinflammatoryboweldisease
_version_ 1725396808988884992